激活丝氨酸/精氨酸丰富蛋白激酶 1（SRPK1）：癌基因还是抑癌基因？
Akt-ing up on SRPK1: oncogene or tumor suppressor?
机构信息
Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
出版信息
Mol Cell. 2014 May 8;54(3):329-30. doi: 10.1016/j.molcel.2014.04.020.
Abstract
In this issue of Molecular Cell, Wang et al. (2014) report that the splicing kinase SRPK1 can function as both an oncogene and a tumor suppressor by modulating the activation state of the protein kinase Akt. This is shown to be mediated by the ability of SRPK1 to bind to the Akt phosphatase PHLPP1.
摘要
在本期《分子细胞》中，Wang 等人（2014 年）报道称剪接激酶 SRPK1 可通过调节蛋白激酶 Akt 的激活状态，充当癌基因和抑癌基因。这是通过 SRPK1 与 Akt 磷酸酶 PHLPP1 结合的能力来介导的。
相似文献
1
Akt-ing up on SRPK1: oncogene or tumor suppressor?激活丝氨酸/精氨酸丰富蛋白激酶 1（SRPK1）：癌基因还是抑癌基因？
Mol Cell. 2014 May 8;54(3):329-30. doi: 10.1016/j.molcel.2014.04.020.
2
Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.无论是 SRPK1 水平降低还是升高，通过干扰 PHLPP 介导的 Akt 去磷酸化，都能促进癌症的发生。
Mol Cell. 2014 May 8;54(3):378-91. doi: 10.1016/j.molcel.2014.03.007. Epub 2014 Apr 3.
3
WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).WD 重复蛋白 WDR48 与去泛素化酶 USP12 形成复合物，通过稳定 PH 结构域富含亮氨酸重复蛋白磷酸酶 1（PHLPP1）来抑制 Akt 依赖性细胞存活信号。
J Biol Chem. 2013 Nov 29;288(48):34545-54. doi: 10.1074/jbc.M113.503383. Epub 2013 Oct 21.
4
Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.SRPK1 对 SRSF1 的磷酸化调节结直肠细胞中肿瘤相关 Rac1b 的可变剪接。
RNA. 2014 Apr;20(4):474-82. doi: 10.1261/rna.041376.113. Epub 2014 Feb 18.
5
Lysosomal mTORC2/PHLPP1/Akt axis: a new point of control of chaperone-mediated autophagy.溶酶体mTORC2/PHLPP1/Akt轴：伴侣蛋白介导的自噬的新控制点
Oncotarget. 2015 Nov 3;6(34):35147-8. doi: 10.18632/oncotarget.5903.
6
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies.长城通过过度激活人类恶性肿瘤中的AKT来促进细胞转化。
Elife. 2015 Nov 27;4:e10115. doi: 10.7554/eLife.10115.
7
Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.pleckstrin homology 结构域富含亮氨酸重复蛋白磷酸酶（PHLPP）：细胞信号转导的新成员。
J Biol Chem. 2012 Feb 3;287(6):3610-6. doi: 10.1074/jbc.R111.318675. Epub 2011 Dec 5.
8
Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.PHLPP1 通过画线介导的膜靶向定位，对于其对 Akt 的负调控作用是必需的。
EMBO Rep. 2011 Jun 24;12(8):818-24. doi: 10.1038/embor.2011.106.
9
The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.磷酸酶 PHLPP1 调控 Akt2，促进胰腺癌细胞死亡，并抑制肿瘤形成。
Gastroenterology. 2012 Feb;142(2):377-87.e1-5. doi: 10.1053/j.gastro.2011.10.026. Epub 2011 Oct 29.
10
Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1.维生素 E 通过磷酸酶 PHLPP1 促进激酶 Akt 的失活。
Sci Signal. 2013 Mar 19;6(267):ra19. doi: 10.1126/scisignal.2003816.
引用本文的文献
1
Rap1 Activity Is Essential for Focal Adhesion and Slit Diaphragm Integrity.Rap1活性对于粘着斑和裂孔隔膜完整性至关重要。
Front Cell Dev Biol. 2022 Mar 18;10:790365. doi: 10.3389/fcell.2022.790365. eCollection 2022.
2
Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.选择性剪接：拓宽癌症生物标志物和治疗学的领域。
Int J Mol Sci. 2020 Nov 27;21(23):9032. doi: 10.3390/ijms21239032.
3
RNA Splicing: A New Paradigm in Host-Pathogen Interactions.RNA 剪接：宿主-病原体相互作用的新范例。
J Mol Biol. 2019 Apr 5;431(8):1565-1575. doi: 10.1016/j.jmb.2019.03.001. Epub 2019 Mar 8.
4
Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.靶向选择性剪接在癌症治疗中的治疗应用。
Int J Mol Sci. 2017 Dec 28;19(1):75. doi: 10.3390/ijms19010075.
5
The double face of Morgana in tumorigenesis.莫尔加娜在肿瘤发生中的双面性。
Oncotarget. 2015 Dec 15;6(40):42603-12. doi: 10.18632/oncotarget.6058.
6
A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12.一项针对犬甲状腺功能减退症的多品种全基因组关联分析确定了CFA12上一个共同的主要风险基因座。
PLoS One. 2015 Aug 11;10(8):e0134720. doi: 10.1371/journal.pone.0134720. eCollection 2015.
7
The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas.SRPK1在转化生长因子-β诱导的食管鳞状细胞癌增殖和凋亡中的关键作用。
Med Oncol. 2015 Jul;32(7):209. doi: 10.1007/s12032-015-0654-3. Epub 2015 Jun 23.
8
The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.常氧条件下SRPK1通过PI3K/Akt信号通路对胶质瘤细胞凋亡、转移及血管生成的影响
Tumour Biol. 2015 Aug;36(8):6083-93. doi: 10.1007/s13277-015-3289-2. Epub 2015 Apr 3.
9
The potential of microRNAs in personalized medicine against cancers.微小RNA在癌症个性化医疗中的潜力。
Biomed Res Int. 2014;2014:642916. doi: 10.1155/2014/642916. Epub 2014 Aug 28.
本文引用的文献
1
Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.无论是 SRPK1 水平降低还是升高，通过干扰 PHLPP 介导的 Akt 去磷酸化，都能促进癌症的发生。
Mol Cell. 2014 May 8;54(3):378-91. doi: 10.1016/j.molcel.2014.03.007. Epub 2014 Apr 3.
2
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.PHLPP 是 RAF1 的负调控因子，可降低结直肠癌细胞的迁移能力，并防止小鼠肿瘤进展。
Gastroenterology. 2014 May;146(5):1301-12.e1-10. doi: 10.1053/j.gastro.2014.02.003. Epub 2014 Feb 11.
3
Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer.磷酸化蛋白质组学筛选揭示了 Akt 同工型特异性信号，将 RNA 处理与肺癌联系起来。
Mol Cell. 2014 Feb 20;53(4):577-90. doi: 10.1016/j.molcel.2013.12.018. Epub 2014 Jan 23.
4
Turning off AKT: PHLPP as a drug target.关闭AKT：以PHLPP作为药物靶点。
Annu Rev Pharmacol Toxicol. 2014;54:537-58. doi: 10.1146/annurev-pharmtox-011112-140338.
5
The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus.Akt-SRPK-SR 轴构成了将 EGF 信号转导到核内调节选择性剪接的主要途径。
Mol Cell. 2012 Aug 10;47(3):422-33. doi: 10.1016/j.molcel.2012.05.014. Epub 2012 Jun 21.
6
Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox.分子在肝癌发生中的相互矛盾作用：范例还是悖论。
Cancer Cell. 2012 Feb 14;21(2):150-4. doi: 10.1016/j.ccr.2012.01.001.
7
Targeting PI3K signalling in cancer: opportunities, challenges and limitations.靶向癌症中的PI3K信号通路：机遇、挑战与局限
Nat Rev Cancer. 2009 Aug;9(8):550-62. doi: 10.1038/nrc2664.
8
AKT/PKB signaling: navigating downstream.AKT/蛋白激酶B信号传导：下游通路解析
Cell. 2007 Jun 29;129(7):1261-74. doi: 10.1016/j.cell.2007.06.009.
9
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.PHLPP及第二种同种型PHLPP2通过调节不同的Akt同种型来差异性地减弱Akt信号传导的幅度。
Mol Cell. 2007 Mar 23;25(6):917-31. doi: 10.1016/j.molcel.2007.02.017.
10
Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.丝氨酸-精氨酸蛋白激酶1的过表达与乳腺癌、结肠癌和胰腺癌中丝裂原活化蛋白激酶途径的致瘤失衡有关。
Cancer Res. 2007 Mar 1;67(5):2072-80. doi: 10.1158/0008-5472.CAN-06-2969.
Zotero 插件